Recombinant activated factor VII for refractory bleeding during pediatric spinal tumor surgery: A case report
DOI:
https://doi.org/10.32677/IJCR.2018.v04.i06.011Keywords:
Refractory bleeding, Spinal tumor, Children, Recombinant activated factor VIIAbstract
Bleeding complications constitute a particular challenge in neurosurgical procedures especially in children and may be life-threatening. We report the case of a 5-month-old boy to whom recombinant activated factor VII was given at doses of 90 ?g/kg of body weight for the control of refractory perioperative bleeding during spinal neurofibromas surgery. Conventional treatment with fresh-frozen plasma, platelet concentrates, and fibrinogen concentrate failed to control hemorrhage. Recombinant activated factor administration resulted in decreased bleeding, hemodynamic stabilization, and improved surgical hemostasis.
Downloads
Published
Issue
Section
License
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.